# Pharmacokinetic Evaluation of Moxifloxacin Administered Intravenously and Orally in Healthy Volunteers Who Have Had a Gastric Bypass

> **NCT01130922** · PHASE4 · COMPLETED · sponsor: **University Ghent** · enrollment: 12 (estimated)

## Conditions studied

- Gastric Bypass
- Body Weight

## Interventions

- **DRUG:** moxifloxacin per IV
- **DRUG:** moxifloxacin per os

## Key facts

- **NCT ID:** NCT01130922
- **Lead sponsor:** University Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2011-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01130922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01130922, "Pharmacokinetic Evaluation of Moxifloxacin Administered Intravenously and Orally in Healthy Volunteers Who Have Had a Gastric Bypass". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01130922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*